Vyant Bio, Inc. (NASDAQ: VYNT) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
Vyant Bio (NASDAQ: VYNT) is an innovative biotechnology company is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The company’s central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Vyant Bio's management believes that drug discovery needs to progressively shift to more efficient methods as the widely used models for…